Travere Therapeutics, Inc. Travere Therapeutics, Inc.

Travere Therapeutics, Inc.

TVTX

Classificação em ações #3489
Travere Therapeutics, Inc. is a biopharmaceutical company developing therapies... Travere Therapeutics, Inc. is a biopharmaceutical company developing therapies for rare kidney and metabolic diseases. Its lead product, FILSPARI (sparsentan), is an oral, once-daily, non-immunosuppressive medication targeting two pathways of disease progression (endothelin-1 and angiotensin-II). Sparsentan received accelerated FDA approval in February 2023 and full approval in September 2024 to slow kidney function decline in adults with primary IgA nephropathy (IgAN) at risk of progression. In April 2026, the FDA approved FILSPARI to reduce proteinuria in adult and pediatric patients aged 8 and older with focal segmental glomerulosclerosis (FSGS) without nephrotic syndrome, making it the first and only FDA-approved medicine for FSGS. The company also markets Thiola and Thiola EC (tiopronin tablets) for cystinuria, a rare genetic disorder causing recurring kidney stones. Its pipeline includes pegtibatinase, an investigational enzyme replacement therapy for classical homocystinuria (HCU). Formerly Retrophin, Inc. (renamed November 2020), Travere is headquartered in San Diego, California, and incorporated in Delaware.
Preço da ação
$52.43
Valor de mercado
$4.94B
Variação (1 dia)
3.83%
Variação (1 ano)
87.97%
País
US
Negociar Travere Therapeutics, Inc. (TVTX)

Categoria

Healthcare
Histórico de desdobramentos de ações de Travere Therapeutics, Inc. (TVTX)
As ações Travere Therapeutics, Inc. (símbolo: TVTX) passaram por um total de 2 desdobramentos.
O desdobramento mais recente ocorreu em Nov 02, 2012.
Uma ação TVTX comprada antes de Jul 02, 2009 equivaleria hoje a 0.0011111111111111 ações TVTX.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
2012-11-02 1:9 x0.11111111111111 x0.0011111111111111
2009-07-02 1:100 x0.01 x0.01
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL